Literature DB >> 18845195

Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.

Jim Jiao1.   

Abstract

Topical dosing of ophthalmic drugs to the eye is a widely accepted route of administration because of convenience, ease of use, and non-invasiveness. However, it has been well recognized that topical ocular delivery endures a low bioavailability due to the anatomical and physiological constraints of the eye which limit drug absorption from the pre-corneal surface. Nonionic surfactants as versatile functional agents in topical ocular drug delivery systems are uniquely suited to meet the challenges through their potential ability to increase bioavailability by increasing drug solubility, prolonging pre-corneal retention, and enhancing permeability. This review attempts to place in perspective the importance of polyoxyethylated nonionic surfactants in the design and development of topical ocular drug delivery systems by assessing their compatibility with common ophthalmic inactive ingredients, their impact on product stability, and their roles in facilitating ocular drugs to reach the target sites.

Mesh:

Substances:

Year:  2008        PMID: 18845195     DOI: 10.1016/j.addr.2008.09.002

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  24 in total

Review 1.  Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.

Authors:  Jie Shen; Guang Wei Lu; Patrick Hughes
Journal:  Pharm Res       Date:  2018-09-25       Impact factor: 4.200

Review 2.  Nanocrystal for ocular drug delivery: hope or hype.

Authors:  Om Prakash Sharma; Viral Patel; Tejal Mehta
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

3.  Evaluation of gatifloxacin pluronic micelles and development of its formulation for ocular delivery.

Authors:  Jovita Kanoujia; Priya Singh Kushwaha; Shubhini A Saraf
Journal:  Drug Deliv Transl Res       Date:  2014-08       Impact factor: 4.617

4.  Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility.

Authors:  Aswani Dutt Vadlapudi; Kishore Cholkar; Ramya Krishna Vadlapatla; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-05       Impact factor: 2.671

5.  Pharmaceutical and Pharmacological Evaluation of the Effect of Nano-Formulated Spironolactone and Progesterone on Inflammation and Hormonal Levels for Managing Hirsutism Experimentally Induced in Rats.

Authors:  Reham I Amer; Ghada E Yassin; Reem A Mohamed; Ahmed M Fayez
Journal:  AAPS PharmSciTech       Date:  2021-07-13       Impact factor: 3.246

6.  Ocular disposition of the hemiglutarate ester prodrug of ∆⁹-Tetrahydrocannabinol from various ophthalmic formulations.

Authors:  Tushar Hingorani; Goutham R Adelli; Nagendra Punyamurthula; Waseem Gul; Mahmoud A Elsohly; Michael A Repka; Soumyajit Majumdar
Journal:  Pharm Res       Date:  2013-06-05       Impact factor: 4.200

7.  Formulation and evaluation of proniosomes containing lornoxicam.

Authors:  Jyotsana R Madan; Nitesh P Ghuge; Kamal Dua
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

8.  Pseudomonas aeruginosa exopolysaccharide Psl promotes resistance to the biofilm inhibitor polysorbate 80.

Authors:  Michael E Zegans; Daniel Wozniak; Edward Griffin; Christine M Toutain-Kidd; John H Hammond; Andrew Garfoot; Joseph S Lam
Journal:  Antimicrob Agents Chemother       Date:  2012-05-14       Impact factor: 5.191

9.  Cloud point extraction of chlorophylls from spinach leaves using aqueous solutions of non-ionic surfactants.

Authors:  Ana Cláudia Leite; Ana M Ferreira; Eduarda S Morais; Imran Khan; Mara G Freire; João A P Coutinho
Journal:  ACS Sustain Chem Eng       Date:  2017-11-08       Impact factor: 8.198

10.  Posaconazole micelles for ocular delivery: in vitro permeation, ocular irritation and antifungal activity studies.

Authors:  Meltem Ezgi Durgun; Emine Kahraman; Mayram Hacıoğlu; Sevgi Güngör; Yıldız Özsoy
Journal:  Drug Deliv Transl Res       Date:  2021-04-08       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.